Jump to content

When will this shit end?


Chrisp1986

Recommended Posts

3 minutes ago, Fuzzy Afro said:

Isn’t Chris Whitty arguing that quick turnaround is more important than capacity? I mean, feel free to disagree with him. But there’s definitely backing in the medical community for what Eustice 

There's backing in all the medical community for rapid accurate testing but this is not being achieved and track & trace is failing too. However Eustace was specifically commenting on rapid testing which at present relies on lateral flow tests. These work best with samples containing high viral loading and have a propensity to give false negatives, hence leaving an infected person to go about their business undetected.

Link to comment
Share on other sites

20 minutes ago, Lycra said:

There's backing in all the medical community for rapid accurate testing but this is not being achieved and track & trace is failing too. However Eustace was specifically commenting on rapid testing which at present relies on lateral flow tests. These work best with samples containing high viral loading and have a propensity to give false negatives, hence leaving an infected person to go about their business undetected.

The tests are for infectiousness are they not? If someone is infected but not infectious, then them going about their business surely isn’t problematic? 

Link to comment
Share on other sites

20 minutes ago, Lycra said:

There's backing in all the medical community for rapid accurate testing but this is not being achieved and track & trace is failing too. However Eustace was specifically commenting on rapid testing which at present relies on lateral flow tests. These work best with samples containing high viral loading and have a propensity to give false negatives, hence leaving an infected person to go about their business undetected.

Is it going to end up being a bit of a numbers game? So yes a few carry on with their business, but if the options are to have that vs NOT doing those extra hundreds of thousands/millions of tests to catch people who otherwise wouldn't be tested, overall we come out ahead?

Link to comment
Share on other sites

1 minute ago, topmarksbri said:

Have Pfizer discussed how they're going to distribute? I know Oxford have discussed earmarking some for 3rd world countries etc. Have to say 1.3bn doesn't seem like a lot when each person will need 2...

Surely they’ll just ramp up production now that we know it works? 

Link to comment
Share on other sites

6 minutes ago, Fuzzy Afro said:

Surely they’ll just ramp up production now that we know it works? 

There's certainly scope for discussions to be had.

I assume the numbers quoted are the absolute maximum based on their own manufacturing capacity - the question is whether or not they're prepared to subcontract / licence out, or to failing that can strike a deal to acquire existing (ie ready to go) manufacturing capacity from elsewhere. If they're the only game in town or significantly more effective than the others, then there'll certainly be significant pressure on them to increase capacity one way or another, and it'll most likely be lucrative to do so.

  • Upvote 1
Link to comment
Share on other sites

19 minutes ago, efcfanwirral said:

Is it going to end up being a bit of a numbers game? So yes a few carry on with their business, but if the options are to have that vs NOT doing those extra hundreds of thousands/millions of tests to catch people who otherwise wouldn't be tested, overall we come out ahead?

Depends on test effectiveness. If 25-50% are false negatives then doesn't get us very far. 

Link to comment
Share on other sites

Guest
This topic is now closed to further replies.
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...